中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
—— |
{(R)-1-[3-Methyl-1-(2-oxo-1,8diaza-cyclotetradec-3-ylcarbamoyl)-butylamino]-propyl}-phosphonic acid |
—— |
C21H43N4O5P |
|
—— |
(R)-icosanoylcarnitine |
—— |
C27H53NO4 |
|
—— |
(R)-2,6-dimethylheptanoylcarnitine |
—— |
C16H31NO4 |
|
—— |
(R)-3-oxopalmitoylcarnitine |
—— |
C23H43NO5 |
|
—— |
(R,R)-chrysanthemoyl CoA |
—— |
C31H46N7O17P3S-4 |
|
—— |
(R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;sulfuric acid;heptahydrate |
—— |
C20H40N2O13S |
|
—— |
(R)-3-Amino-4-(4-hydroxyphenyl)butanoic acid |
—— |
C10H13NO3 |
|
—— |
ricinoleoyl-CoA |
—— |
C39H64N7O18P3S-4 |
|
—— |
Ribosyl hopane |
—— |
C35H60O4 |
|
—— |
Rel-(3aR,4R,7S,7aS)-4-methyl-3a,4,7,7a-tetrahydro-4,7-epoxyisobenzofuran-1,3-dione |
—— |
C9H8O4 |
|
—— |
(R)-1-(2-((4-(4-phenoxyphenoxy)-5H-pyrrolo[3,2-d]pyrimidin-5-yl)methyl)azetidin-1-yl)prop-2-en-1-one |
—— |
C25H22N4O3 |
|
—— |
(R)-(-)-Nalpha-BENZYL-Nbeta-BOC-D-HYDRAZINOALANINE DICYCLOHEXYLAMINE SALT |
—— |
C27H45N3O4 |
|
—— |
(R)-N-(1-(4-chlorophenyl)ethyl)-10-methyl-11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxamide 5-oxide |
—— |
C23H19ClN2O3S |
|
—— |
(R)-2-((2-Aminothieno[3,2-D]pyrimidin-4-YL)amino)hexan-1-OL |
—— |
C12H18N4OS |
|
—— |
(R)-1-(1-acryloylpiperidin-3-yl)-5-amino-3-(3-methoxy-4-methylphenyl)-1H-pyrazole-4-carboxamide |
—— |
C20H25N5O3 |
|
—— |
(R)-N-[5-[2-(7,7-dimethyl-4-oxo-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-3-yl)-3-(hydroxymethyl)-4-pyridyl]-1-methyl-2-oxo-3-pyridyl]spiro[2.2]pentane-2-carboxamide |
—— |
C30H33N5O4 |
|
—— |
(R)-1-(1-acryloylpiperidin-3-yl)-5-amino-3-(4-chlorophenyl)-1H-pyrazole-4-carboxamide |
—— |
C18H20ClN5O2 |
|
—— |
(R)-N-[5-[2-(7,7-dimethyl-4-oxo-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-3-yl)-3-(hydroxymethyl)-4-pyridyl]-1-methyl-2-oxo-3-pyridyl]spiro[2.2]pentane-2-carboxamide |
—— |
C30H35N5O5 |
|
—— |
(R)-N-[5-[2-(7,7-dimethyl-4-oxo-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-3-yl)-3-(hydroxymethyl)-4-pyridyl]-1-methyl-2-oxo-3-pyridyl]spiro[2.3]hexane-2-carboxamide |
—— |
C31H35N5O4 |
|
—— |
Rac1 Inhibitor W56 |
—— |
C74H117N19O23S |
|
—— |
[Ru(bpy)<sub>2</sub>(PMe<sub>3</sub>)(GABA)]Cl |
—— |
C27H33N5O2PRu*Cl |
|
—— |
Rac1 Inhibitor F56, control peptide |
—— |
C72H116N18O23S |
|
—— |
RKI 1447 dihydrochloride |
—— |
C16H16Cl2N4O2S |
|
—— |
(R)-amfepentorex maleate |
—— |
C19H29NO4 |
|
—— |
rac-(1S,2R)-2-(tert-butoxycarbonylamino)cyclopent-3-ene-1-carboxylic acid |
—— |
C11H17NO4 |
|
—— |
(R)-2-((1-(2-(3-(2-Fluoroethoxy)-4-Methoxyphenyl)-5-Propylthiazol-4-Yl)ethyl)thio)pyrimidine-4,6-Diamine |
—— |
C21H26FN5O2S2 |
|
—— |
(R)-N-(1-(isoxazol-5-yl)-3-methylpentan-3-yl)-2,6-dimethoxybenzamide |
—— |
C18H24N2O4 |
|
—— |
(R)-2,2'-Binaphthyl-20-crown-6 |
—— |
C34H40O6 |
|
—— |
(R)-2-Methyl-tetrahydrofuran-2-carbonsaeure-N-methylamid |
61449-99-8 |
C7H13NO2 |
|
—— |
(R)-(+)-1-[(R)-2-(Diphenylphosphino)ferrocenyl]ethyldicyclohexylphosphine |
—— |
C36H44FeP2 |
|
—— |
RFRP-3 (rat) |
—— |
C88H134N26O25S2 |
|
—— |
(R)-2-(((4S,5S)-1-methyl-4,5-diphenylimidazolidin-2-ylidene)amino)-3-phenylpropan-1-ol |
—— |
C25H27N3O |
|
—— |
(R)-2-tert-Butoxycarbonylamino-3-ethylsulfanyl-propionic acid; compound with dicyclohexyl-amine |
—— |
C10H19NO4S*C12H23N |
|
—— |
rac-Dimethylsilylenebis(2-methylindenyl)dimethylzirconium |
—— |
C24H28SiZr |
|
—— |
(R)-4-Hydroxy Propranolol Hydrochloride |
—— |
C16H22ClNO3 |
|
—— |
(R)-N-(2,4-difluorobenzyl)-7-hydroxy-5-isopropyl-6,8-dioxo-3,3a,4,5,6,8-hexahydro-1H-2-oxa-3a,5-diazaphenalene-9-carboxamide |
—— |
C21H21F2N3O5 |
|
—— |
(R)-(1-methylpyrrolidin-3-yl)(5-fluoro-3'-(trifluoromethyl)[1,1'-biphenyl]-2-yl)carbamate |
—— |
C20H20F4N2O2 |
|
—— |
[(R)-methoxy-[1-[6-(methoxyamino)-9-trityl-6H-purin-3-yl]propan-2-yloxy]methyl]phosphonic acid |
—— |
C30H34N5O6P |
|
—— |
[(R)-fluoro-[(2S)-1-[6-(methoxyamino)-9-trityl-6H-purin-3-yl]propan-2-yl]oxymethyl]phosphonic acid |
—— |
C29H31FN5O5P |
|
—— |
(R,E)-1-(1-cinnamylpiperid-4-yl)-2-(pyrrolidin-3-yl)-1H-benzo[d]imidazole |
—— |
C25H30N4 |
|
—— |
(R/S) tert-butyl N-(2-[[(3-[1,1-dimethyl-2-oxaspiro[4.5]decan-8-yl]-1-(oxan-2-yl)-1H-pyrazol-4-yl)methyl](methyl)amino]ethyl)-N-methylcarbamate |
—— |
C29H50N4O4 |
|
—— |
(R/S) tert-butyl N-(2-[[(3-[1,1-dimethyl-2-oxaspiro[4.5]dec-7-en-8-yl]-1-(oxan-2-yl)-1H-pyrazol-4yl)methyl](methyl)amino]ethyl)-N-methylcarbamate |
—— |
C29H48N4O4 |
|
—— |
(R)-(9H-fluoren-9-yl)methyl 2-(((R)-(1-benzyl-4-(2,5-difluorophenyl)-1H-imidazol-2-yl)(tetrahydro-2H-pyran-4-yl)methyl)(((3R,4R)-1-(tert-butoxycarbonyl)-4-fluoropyrrolidin-3-yl)methyl)carbamoyl)morpholine-4-carboxylate |
—— |
C52H56F3N5O7 |
|
—— |
(R)-1-(2-chloro-5-fluoropyrimidin-4-yl)-4-hydroxypyrrolidin-2-one |
—— |
C8H7ClFN3O2 |
|
—— |
(R)-1-(2-(((S)-1-(1-(4-chlorophenyl)-1H-imidazol-4-yl)ethyl)amino)-5-fluoropyrimidin-4-yl)-4-hydroxypyrrolidin-2-one |
—— |
C19H18ClFN6O2 |
|
—— |
(R)-tert-butyl 3-(2-((1-(1-benzyl-4-(2,5-difluorophenyl)-1H-imidazol-2-yl)-4-((2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)amino)-2,2-dimethyl-4-oxobutyl)carbamoyl)phenoxy)azetidine-1-carboxylate |
—— |
C43H46F2N6O7 |
|
—— |
(R)-methyl 2-amino-2-(4-hydroxytetrahydro-2H-pyran-4-yl)acetate |
—— |
C8H15NO4 |
|
—— |
(R)-1-(1-benzyl-4-(2,5-difluorophenyl)-1H-imidazol-2-yl)-2,2-dimethylbut-3-en-1-amine |
—— |
C22H23F2N3 |
|
—— |
(R)-4-((S)-2-((S)-2-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)-3-methylbutanamido)-5-ureidopentanamido)benzyl 3-(((S)-N-((R)-(1-benzyl-4-(2,5-difluorophenyl)-1H-imidazol-2-yl)(tetrahydro-2H-pyran-4-yl)methyl)-2-hydroxypropanamido)methyl)pyrrolidine-1-carboxylate |
—— |
C59H74F2N10O11 |
|
—— |
(R)-6'-ethoxy-2-methyl-5'-(3-methylmorpholino)-[3,3'-bipyridin]-5-amine |
—— |
C18H24N4O2 |
|